Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.

Clinical trial NCT00330499 · COMPLETED

Trial details

NCT number: NCT00330499
Sponsor: Trans Tasman Radiation Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transitional Cell Carcinoma of Urinary Bladder

Start date: 2002-10-01
Primary completion: 2010-02-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.